A Study to Evaluate the Pharmacokinetics and Safety of GSK1265744 and Rilpivirine and Dolutegravir and Rilpivirine in Healthy Adult Subjects

NCT01467531 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

28

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Human Immunodeficiency Virus and Hepatitis

Interventions

DRUG: Dolutegravir
DRUG: Rlipivirine
DRUG: GSK1265744

Sponsor

ViiV Healthcare

Collaborators

[object Object]